University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Chi-Yuan Hsu, M.D.

Kidney specialist

Clinics

Nephrology, Hypertension and Metabolism Practice at Parnassus
400 Parnassus Ave., Fifth Floor
San Francisco, CA 94143-0532
Phone: (415) 353-2507
Fax: (415) 353-2568
New Referrals: (415) 476-2173
New Referrals Fax: (415) 476-3381

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Chi-Yuan Hsu

Additional Languages

Cantonese
Mandarin

Education

Harvard University School of Medicine 1993

Residencies

Boston's Beth Israel Hospital, Internal Medicine 1996

Fellowships

Massachusetts General Hospital, Nephrology 1998

Selected Research and Publications

  1. Park M, Hsu CY. An ACE in the Hole for Patients With Advanced Chronic Kidney Disease? JAMA Intern Med. 2014 Mar 1; 174(3):355-6.
  2. Hsu CY, Liu KD. Cardiovascular Events after AKI: A New Dimension. J Am Soc Nephrol. 2014 Mar; 25(3):425-7.
  3. Lin YC, Bansal N, Vittinghoff E, Go AS, Hsu CY. Determinants of the creatinine clearance to glomerular filtration rate ratio in patients with chronic kidney disease: a cross-sectional study. BMC Nephrol. 2013; 14(1):268.
  4. Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ. APOL1 risk variants, race, and progression of chronic kidney disease. N Engl J Med. 2013 Dec 5; 369(23):2183-96.
  5. Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD. Urine stability studies for novel biomarkers of acute kidney injury. Am J Kidney Dis. 2014 Apr; 63(4):567-72.
  6. Yang W, Xie D, Anderson AH, Joffe MM, Greene T, Teal V, Hsu CY, Fink JC, He J, Lash JP, Ojo A, Rahman M, Nessel L, Kusek JW, Feldman HI. Association of Kidney Disease Outcomes With Risk Factors for CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2014 Feb; 63(2):236-43.
  7. Fisher H, Hsu CY, Vittinghoff E, Lin F, Bansal N. Comparison of Associations of Urine Protein-Creatinine Ratio Versus Albumin-Creatinine Ratio With Complications of CKD: A Cross-sectional Analysis. Am J Kidney Dis. 2013 Dec; 62(6):1102-8.
  8. Hsu RK, McCulloch CE, Ku E, Dudley RA, Hsu CY. Regional variation in the incidence of dialysis-requiring AKI in the United States. Clin J Am Soc Nephrol. 2013 Sep; 8(9):1476-81.
  9. Hsu RK, Hsu CY. Temporal Trends in Prevalence of CKD: The Glass Is Half Full and Not Half Empty. Am J Kidney Dis. 2013 Aug; 62(2):214-6.
  10. Bansal N, He C, Murphy DP, Johansen KL, Hsu CY. Timing of preemptive vascular access placement: do we understand the natural history of advanced CKD?: an observational study. BMC Nephrol. 2013 May 28; 14(1):115.
  11. Murphy DP, Hsu CY. Estimating glomerular filtration rate: is it good enough? And is it time to move on? Curr Opin Nephrol Hypertens. 2013 May; 22(3):310-5.
  12. Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R. Estimating prevalence of CKD stages 3-5 using health system data. Am J Kidney Dis. 2013 Jun; 61(6):930-8.
  13. Park M, Vittinghoff E, Liu KD, Shlipak MG, Hsu CY. Urine Biomarkers Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule-1 (KIM-1) Have Different Patterns in Heart Failure Exacerbation. Biomark Insights. 2013; 8:15-8.
  14. Bansal N, Keane M, Delafontaine P, Dries D, Foster E, Gadegbeku CA, Go AS, Hamm LL, Kusek JW, Ojo AO, Rahman M, Tao K, Wright JT, Xie D, Hsu CY. A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol. 2013 Mar; 8(3):355-62.
  15. Tuot DS, Plantinga LC, Judd SE, Muntner P, Hsu CY, Warnock DG, Gutiérrez OM, Safford M, Powe NR, McClellan WM. Healthy behaviors, risk factor control and awareness of chronic kidney disease. Am J Nephrol. 2013; 37(2):135-43.
  16. Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 2013 May; 83(5):909-14.
  17. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS. Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation. 2013 Feb 5; 127(5):569-74.
  18. Hsu RK, McCulloch CE, Dudley RA, Lo LJ, Hsu CY. Temporal changes in incidence of dialysis-requiring AKI. J Am Soc Nephrol. 2013 Jan; 24(1):37-42.
  19. Plantinga LC, Tuot DS, Grubbs V, Hsu CY, Powe NR. Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference? J Urban Health. 2012 Dec; 89(6):965-76.
  20. Hsu CY. CKD-EPI eGFR categories were better than MDRD categories for predicting mortality in a range of populations. Ann Intern Med. 2012 Nov 20; 157(10):JC5-12.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.